Novo Nordisk A/S 2014 AR2
The report highlights Novo Nordisk's financial, social, and environmental performance for the fiscal year 2014. The company achieved an 8% sales growth in local currencies and a 10% increase in operating profit, driven by key products like Levemir and Victoza. On the social front, Novo Nordisk reached an estimated 24.4 million patients with its diabetes care products and improved diversity in its senior management teams to 76%. Environmentally, the company successfully met its long-term target of reducing carbon dioxide emissions from energy consumption by 45% compared to the 2004 baseline.
Company: Novo Nordisk A/S
Sector: Manufacturing
Country: Denmark
Year: 2014
Type: AR2
Pages: 116
Back to company
Novo Nordisk A/S
Annual Report
The report highlights Novo Nordisk's financial, social, and environmental performance for the fiscal year 2014. The company achieved an 8% sales growth in local currencies and a 10% increase in operating profit, driven by key products like Levemir and Victoza. On the social front, Novo Nordisk reached an estimated 24.4 million patients with its diabetes care products and improved diversity in its senior management teams to 76%. Environmentally, the company successfully met its long-term target of reducing carbon dioxide emissions from energy consumption by 45% compared to the 2004 baseline.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2014 - Dec 31, 2014
Fiscal Year
2014
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees